You are here

  • Home
  • Archive
  • Volume 74, Issue Suppl 2
  • AB0200 The Ineffectiveness of Relaxin Treatment to Ameliorate Dermal Fibrosis in Systemic Sclerosis Could be Due to Relaxin Receptor Alterations

Article info

Article menu
Download PDFPDF
Abstracts Accepted for Publication
Scleroderma, myositis and related syndromes - etiology, pathogenesis and animal models
AB0200 The Ineffectiveness of Relaxin Treatment to Ameliorate Dermal Fibrosis in Systemic Sclerosis Could be Due to Relaxin Receptor Alterations

Authors

Citation

Corallo C, Carrarelli P, Gianfrancesco F, et al
AB0200 The Ineffectiveness of Relaxin Treatment to Ameliorate Dermal Fibrosis in Systemic Sclerosis Could be Due to Relaxin Receptor Alterations
Annals of the Rheumatic Diseases 2015;74:957-958.

Publication history

  • First published June 9, 2015.
Online issue publication 
April 13, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2015, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions